Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data

Tekijä Armstrong, April W., Koning, J. Will, Rowse, Simon, Tan, Huaming, Mamolo, Carla, Kaur, Mandeep
Julkaisussa Dermatol Ther (Heidelb) (2016)

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies

Tekijä Callis Duffin, Kristina, Bushmakin, Andrew G., Cappelleri, Joseph C., Mallbris, Lotus, Mamolo, Carla
Julkaisussa BMC Dermatol (2019)

Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes

Tekijä Panés, Julián, Su, Chinyu, Bushmakin, Andrew G, Cappelleri, Joseph C, Mamolo, Carla, Healey, Paul
Julkaisussa BMC Gastroenterol (2015)

Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom

Tekijä Castejón, Nacho, Cappelleri, Joseph C., Cuervo, Jesús, Lang, Kathryn, Mehta, Priyanka, Mokgokong, Ruth, Mamolo, Carla
Julkaisussa Health Qual Life Outcomes (2018)

Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews

Tekijä Lee, Lauren J, Kwon, Christina S, Forsythe, Anna, Mamolo, Carla M, Masters, Elizabeth T, Jacobs, Ira A
Julkaisussa Clinicoecon Outcomes Res (2020)

Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia

Tekijä Mamolo, Carla, Welch, Verna, Walter, Roland B., Cappelleri, Joseph C., Brockbank, James, Cawson, Matthew, Knight, Chris, Wilson, Michele
Julkaisussa Pharmacoeconomics (2020)

Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia

Tekijä Brümmendorf, Tim H., Gambacorti-Passerini, Carlo, Bushmakin, Andrew G., Cappelleri, Joseph C., Viqueira, Andrea, Reisman, Arlene, Isfort, Susanne, Mamolo, Carla
Julkaisussa Ann Hematol (2020)

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial

Tekijä Papp, Kim A., Bissonnette, Robert, Gooderham, Melinda, Feldman, Steven R., Iversen, Lars, Soung, Jennifer, Draelos, Zoe, Mamolo, Carla, Purohit, Vivek, Wang, Cunshan, Ports, William C.
Julkaisussa BMC Dermatol (2016)

Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or int...

Tekijä Kantarjian, Hagop M., Mamolo, Carla M., Gambacorti‐Passerini, Carlo, Cortes, Jorge E., Brümmendorf, Tim H., Su, Yun, Reisman, Arlene L., Shapiro, Mark, Lipton, Jeff H.
Julkaisussa Cancer (2017)

Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses

Tekijä Baker, Erica L., Coleman, Craig I., Reinhart, Kurt M., Phung, Olivia J., Kugelman, Lisa, Chen, Wendy, White, C. Michael, Mamolo, Carla M., Cappelleri, Joseph C., Baker, William L.
Julkaistu 2012